ShK from the sea anemone S. helianthus has been used as a scaffold to develop a highly selective Kv1.3 blocking peptide ShK-186, which is undergoing clinical trials for treatment of autoimmune disease [62]. Here, KCNA3 is linked to autoimmune disease.